An investigation into the use of the E1 gene as a target gene for molecular detection and differentiation of HR-HPV types

Read full text Summarise with VIRAT
Authors: Shannon Reina
Cited by: 0
References: 145

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Human Papillomavirus (HPV) is the most diagnosed sexually transmitted infection (STI) in the world and high risk (HR-HPV) types are associated with 96% of cervical cancer cases. Cervical cancer is the fourth leading cause of cancer death amongst women and screening for cervical cancer has led to a 70% reduction in deaths. Medical professionals currently use the HPV vaccine and screening to prevent the spread of HPV and to diagnose precancerous lesions in the cervix before they develop to late grade cancer. The World Health Organisation (WHO) recommends that HPV testing be used as a primary screening method as a positive HR-HPV result is indicative of cervical cancer risk. However, the tests currently available are not specific enough as they can only detect HR-HPV types; they cannot distinguish between them. None of the HPV assays which are currently commercially available have used the E1 gene as a target for molecular detection. This project aims to investigate the use of the E1 gene as a target for molecular detection and differentiation of multiple HR-HPV types.

Fields of Study & Subjects

Cervical Cancer and HPV Research Reproductive tract infections research Biosensors and Analytical Detection

Publication details

Journal / source
Arrow - TU Dublin (Technological University Dublin)
Publication date
30 March 2026
Language
EN
Document type
Thesis